Related Experiment Video
Updated: May 2, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
14.4K
Reperfusion therapies for acute ischemic stroke: an update
Laura Dorado, Mònica Millán, Antoni Dávalos1
1Stroke Unit, Department of Neurosciences, Hospital Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain. mmillan.germanstrias@gencat.cat.
Current Cardiology Reviews
|March 21, 2014
Summary
Acute ischemic stroke treatment is limited by a narrow time window. Newer stent-based devices show promise for faster clot removal, potentially expanding treatment eligibility and improving outcomes.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Medical Devices
Background:
- Acute ischemic stroke is a leading cause of death and disability globally.
- Current treatment, intravenous thrombolysis with tissue plasminogen activator (tPA), has a restrictive 4.5-hour window, limiting patient eligibility.
- Limited treatment windows necessitate exploration of advanced reperfusion strategies.
Purpose of the Study:
- To review systemic thrombolytic trials for acute ischemic stroke.
- To summarize the efficacy of endovascular approaches, including newer thrombectomy devices.
- To assess the potential of mechanical clot removal to improve patient outcomes.
Main Methods:
- Review of major systemic thrombolytic trials.
- Analysis of recent endovascular trials utilizing various thrombectomy devices.
- Comparison of first-generation devices with newer stent-based systems.
Main Results:
- Intravenous tPA significantly improves outcomes but has a narrow therapeutic window.
- Endovascular therapies, particularly stent-retrievers, demonstrate higher revascularization rates and faster recanalization times.
- While effective in opening vessels, randomized trials are needed to confirm improved patient outcomes with stent-based devices.
Conclusions:
- Mechanical thrombectomy, especially with stent-retrievers, offers a promising alternative for acute ischemic stroke.
- Further randomized clinical trials are crucial to establish the definitive efficacy of these devices in improving patient outcomes.
- Expanding treatment options beyond the tPA window is essential for managing acute ischemic stroke.
More Related Videos
Related Concept Videos
01:15Ischemic Stroke ll: Pathophysiology
54
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
01:28Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
01:15Ischemic Stroke l: Introduction
44
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
44
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
01:26Transient Ischemic Attack l: Introduction
18
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
18